Takeda Avoids Most Claims In Actos Buyers' Antitrust Suit
By Matt Bernardini ( October 8, 2019, 6:45 PM EDT) -- Japanese pharmaceutical company Takeda scored a big win Tuesday when a New York federal judge agreed to dismiss all claims but one in a suit accusing the company of delaying generic competition for its diabetes drug Actos....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.